The RTÉ favourite revealed that her daughter spent three days in Crumlin Children's Hospital after contracting RSV and she ...

Health officials are urging folks to get their flu and COVID vaccines as we head into the colder months because that’s when ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

Not making COVID-19 and flu vaccines available to family physicians could adversely impact public willingness and access to ...

Algoma Public Health (APH) encourages residents to get COVID-19 and flu vaccines as soon as shots are available. “Both ...

Dr. Victoria Weston, emergency medicine physician, Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about the difference between and emergency department and an urgent care ...

Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...

GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...

Pfizer has terminated development of its RSV treatment candidate sisunatovir, a viral inhibitor picked up in its up to $525 ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and GSK said it expects revaccination will eventually be needed.

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...